Repligen Total Assets 2006-2019 | RGEN

Repligen total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Repligen total assets for the quarter ending September 30, 2019 were $1.379B, a 80.9% increase year-over-year.
  • Repligen total assets for 2018 were $0.775B, a 4.18% increase from 2017.
  • Repligen total assets for 2017 were $0.744B, a 157.35% increase from 2016.
  • Repligen total assets for 2016 were $0.289B, a 97.56% increase from 2015.
Repligen Annual Total Assets
(Millions of US $)
2018 $775
2017 $744
2016 $289
2015 $146
2014 $128
2013 $119
2012 $97
2011 $76
2011 $72
2010 $71
2009 $74
2008 $69
2007 $29
2006 $29
2005 $28
Repligen Quarterly Total Assets
(Millions of US $)
Q3 2019 $1,379
Q2 2019 $1,068
Q1 2019 $798
Q4 2018 $775
Q3 2018 $762
Q2 2018 $745
Q1 2018 $743
Q4 2017 $744
Q3 2017 $734
Q2 2017 $309
Q1 2017 $291
Q4 2016 $289
Q3 2016 $285
Q2 2016 $282
Q1 2016 $147
Q4 2015 $146
Q3 2015 $140
Q2 2015 $137
Q1 2015 $129
Q4 2014 $128
Q3 2014 $129
Q2 2014 $129
Q1 2014 $119
Q4 2013 $119
Q3 2013 $112
Q2 2013 $105
Q1 2013 $97
Q4 2012 $97
Q3 2012 $85
Q2 2012 $81
Q1 2012 $80
Q4 2011 $76
Q3 2011 $73
Q2 2011 $72
Q1 2011 $72
Q4 2010 $73
Q3 2010 $73
Q2 2010 $72
Q1 2010 $71
Q4 2009 $72
Q3 2009 $72
Q2 2009 $71
Q1 2009 $74
Q4 2008 $75
Q3 2008 $76
Q2 2008 $76
Q1 2008 $69
Q4 2007 $70
Q3 2007 $71
Q2 2007 $30
Q1 2007 $29
Q4 2006 $29
Q3 2006 $28
Q2 2006 $29
Q1 2006 $29
Q4 2005 $29
Q3 2005 $29
Q2 2005 $29
Q1 2005 $28
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $5.292B $0.194B
Repligen Corporation is a life sciences company focused on the development, production and commercialization of high-value consumable products used in the process of manufacturing biological drugs. Their bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. They are a leading manufacturer of Protein A, a critical reagent used to separate and purify monoclonal antibody therapeutics. They also supply several growth factor products used to increase cell culture productivity during the fermentation stage of drug manufacturing. In addition, they have developed and marketed their OPUS? series of pre-packed `plug-and-play` chromatography columns, and they provide test kits to ensure final product quality. Aside from their core bioprocessing business, they have a portfolio of clinical-stage partnering assets, including a pancreatic imaging agent in Phase 3 development and an orphan drug candidate in Phase 1 development.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $133.596B 15.39
CSL (CSLLY) Australia $96.833B 0.00
Gilead Sciences (GILD) United States $81.425B 10.09
Vertex Pharmaceuticals (VRTX) United States $59.651B 60.88
Biogen (BIIB) United States $50.876B 8.73
Illumina (ILMN) United States $46.199B 50.69
Regeneron Pharmaceuticals (REGN) United States $37.778B 16.54
Alexion Pharmaceuticals (ALXN) United States $23.671B 11.69
Seattle Genetics (SGEN) United States $19.355B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.624B 0.00
Incyte (INCY) United States $16.469B 38.23
BioMarin Pharmaceutical (BMRN) United States $15.428B 0.00
Genmab (GNMSF) Denmark $13.600B 60.07
Alnylam Pharmaceuticals (ALNY) United States $12.790B 0.00
Galapagos (GLPG) Belgium $12.624B 32.53
Exact Sciences (EXAS) United States $11.777B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.238B 53.94
BeiGene (BGNE) Cayman Islands $9.724B 0.00
Sarepta Therapeutics (SRPT) United States $8.791B 0.00
Bio-Techne Corp (TECH) United States $8.325B 55.72
QIAGEN (QGEN) Netherlands $7.749B 25.26
BioNTech SE (BNTX) Germany $7.743B 0.00
Moderna (MRNA) United States $7.451B 0.00
Guardant Health (GH) United States $7.385B 0.00
Amarin (AMRN) Ireland $7.237B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.810B 17.31
ACADIA Pharmaceuticals (ACAD) United States $6.400B 0.00
Reata Pharmaceuticals (RETA) United States $5.885B 0.00
Ascendis Pharma (ASND) Denmark $5.730B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.472B 0.00
Exelixis (EXEL) United States $5.433B 15.28
Bluebird Bio (BLUE) United States $4.646B 0.00
China Biologic Products (CBPO) China $4.570B 25.74
Acceleron Pharma (XLRN) United States $4.214B 0.00
MorphoSys AG (MOR) Germany $4.105B 0.00
Adaptive Biotechnologies (ADPT) United States $3.866B 0.00
Mirati Therapeutics (MRTX) United States $3.565B 0.00
Immunomedics (IMMU) United States $3.546B 0.00
NeoGenomics (NEO) United States $3.527B 187.67
Zai Lab (ZLAB) China $3.214B 0.00
Blueprint Medicines (BPMC) United States $3.204B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.179B 0.00
MyoKardia (MYOK) United States $3.178B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.093B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.055B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.971B 0.00
Genmab (GMAB) Denmark $2.896B 5.97
Emergent Biosolutions (EBS) United States $2.878B 28.59
Halozyme Therapeutics (HALO) United States $2.846B 0.00
Alkermes (ALKS) Ireland $2.799B 0.00
UniQure (QURE) Netherlands $2.669B 0.00
Denali Therapeutics (DNLI) United States $2.385B 0.00
Amicus Therapeutics (FOLD) United States $2.293B 0.00
RA PHARMCTL INC (RARX) United States $2.223B 0.00
Arena Pharmaceuticals (ARNA) United States $2.201B 5.12
Myriad Genetics (MYGN) United States $2.160B 31.91
Epizyme (EPZM) United States $1.986B 0.00
Fate Therapeutics (FATE) United States $1.934B 0.00
Insmed (INSM) United States $1.850B 0.00
Akcea Therapeutics (AKCA) United States $1.770B 0.00
Arvinas (ARVN) United States $1.742B 0.00
Zymeworks (ZYME) Canada $1.715B 0.00
Alector (ALEC) United States $1.695B 0.00
Principia Biopharma (PRNB) United States $1.679B 0.00
REGENXBIO (RGNX) United States $1.602B 0.00
Ligand Pharmaceuticals (LGND) United States $1.546B 29.74
Editas Medicine (EDIT) United States $1.449B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.362B 0.00
Coherus BioSciences (CHRS) United States $1.325B 0.00
Intra-Cellular Therapies (ITCI) United States $1.320B 0.00
Zealand Pharma (ZLDPF) Denmark $1.292B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.286B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.275B 0.00
Zealand Pharma (ZEAL) Denmark $1.141B 0.00
Athenex (ATNX) United States $1.106B 0.00
DBV Technologies S.A (DBVT) France $1.022B 0.00
Revance Therapeutics (RVNC) United States $1.008B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.988B 0.00
Mesoblast (MESO) Australia $0.970B 0.00
Codexis (CDXS) United States $0.963B 0.00
PHARMA MAR SA (PHMMF) Spain $0.958B 0.00
Pharming Group (PHGUF) Netherlands $0.869B 0.00
Sangamo Therapeutics (SGMO) United States $0.842B 0.00
Heska (HSKA) United States $0.811B 207.14
ZIOPHARM Oncology Inc (ZIOP) United States $0.795B 0.00
Twist Bioscience (TWST) United States $0.794B 0.00
Vericel (VCEL) United States $0.750B 279.50
ANI Pharmaceuticals (ANIP) United States $0.742B 12.65
Vanda Pharmaceuticals (VNDA) United States $0.734B 6.17
Cytokineticsorporated (CYTK) United States $0.730B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.708B 0.00
Cellectis S.A (CLLS) France $0.700B 0.00
Adverum Biotechnologies (ADVM) United States $0.689B 0.00
Retrophin (RTRX) United States $0.687B 0.00
Sorrento Therapeutics (SRNE) United States $0.680B 0.00
GENFIT S.A (GNFT) France $0.670B 0.00
NantKwest (NK) United States $0.660B 0.00
Intellia Therapeutics (NTLA) United States $0.657B 0.00
Cara Therapeutics (CARA) United States $0.649B 0.00
Anika Therapeutics (ANIK) United States $0.645B 20.93
UROGEN PHARMA (URGN) United States $0.628B 0.00
AC Immune SA (ACIU) Switzerland $0.595B 13.75
Kadmon Holdings (KDMN) United States $0.589B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.553B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.540B 0.00
Prothena (PRTA) Ireland $0.540B 0.00
Cel-Sci (CVM) United States $0.510B 0.00
Agenus (AGEN) United States $0.509B 0.00
Bellus Health (BLU) Canada $0.504B 0.00
BioDelivery Sciences (BDSI) United States $0.494B 0.00
Precision BioSciences (DTIL) United States $0.463B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Clovis Oncology (CLVS) United States $0.460B 0.00
Arcus Biosciences (RCUS) United States $0.443B 0.00
Inovio Pharmaceuticals (INO) United States $0.436B 0.00
Dynavax Technologies (DVAX) United States $0.424B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.415B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.404B 0.00
Merus (MRUS) Netherlands $0.402B 0.00
AnaptysBio (ANAB) United States $0.398B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.396B 0.00
Avid Bioservices (CDMO) United States $0.375B 0.00
Cue Biopharma (CUE) United States $0.372B 0.00
Compugen (CGEN) Israel $0.370B 0.00
PDL BioPharma (PDLI) United States $0.369B 9.23
Kindred Biosciences (KIN) United States $0.361B 0.00
Mersana Therapeutics (MRSN) United States $0.359B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.356B 2.46
Pfenex (PFNX) United States $0.354B 0.00
OSMOTICA PHARM (OSMT) United States $0.348B 0.00
CytomX Therapeutics (CTMX) United States $0.345B 0.00
Gritstone Oncology (GRTS) United States $0.336B 0.00
Stemline Therapeutics (STML) United States $0.330B 0.00
Cellular Biomedicine (CBMG) United States $0.330B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.327B 0.00
Puma Biotechnology (PBYI) United States $0.325B 0.00
MannKind (MNKD) United States $0.322B 0.00
Syros Pharmaceuticals (SYRS) United States $0.308B 0.00
Albireo Pharma (ALBO) United States $0.308B 0.00
POXEL SA FRANCE (PXXLF) France $0.303B 0.00
IVERIC Bio (ISEE) United States $0.296B 0.00
Starpharma Holdings (SPHRY) Australia $0.286B 0.00
Geron (GERN) United States $0.270B 0.00
Kamada (KMDA) Israel $0.265B 7.73
WAVE Life Sciences (WVE) Singapore $0.258B 0.00
ChromaDex (CDXC) United States $0.257B 0.00
Biofrontera AG (BFRA) Germany $0.252B 0.00
VBI Vaccines (VBIV) United States $0.251B 0.00
ADMA Biologics Inc (ADMA) United States $0.243B 0.00
Sutro Biopharma (STRO) United States $0.239B 0.00
Prometic Life Sciences (LMNL) Canada $0.236B 0.00
Novavax (NVAX) United States $0.230B 0.00
Seres Therapeutics (MCRB) United States $0.225B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.222B 0.00
Athersys (ATHX) United States $0.221B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.220B 0.00
Theratechnologies (THTX) Canada $0.219B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.214B 0.00
Affimed (AFMD) Germany $0.212B 0.00
Exicure (XCUR) United States $0.212B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.210B 0.00
XOMA (XOMA) United States $0.204B 0.00
Protagonist Therapeutics (PTGX) United States $0.201B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.198B 0.00
Cerecor (CERC) United States $0.198B 0.00
Spero Therapeutics (SPRO) United States $0.191B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.188B 0.00
Aptinyx (APTX) United States $0.186B 0.00
Five Prime Therapeutics (FPRX) United States $0.185B 0.00
Fortress Biotech (FBIO) United States $0.174B 0.00
CorMedix Inc (CRMD) United States $0.174B 0.00
TELA Bio (TELA) United States $0.173B 0.00
Windtree Therapeutics (WINT) United States $0.172B 0.00
Arbutus Biopharma (ABUS) Canada $0.171B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.171B 8.77
Strongbridge Biopharma (SBBP) United States $0.170B 4.55
Alcobra (ARCT) United States $0.164B 0.00
Palatin Technologies (PTN) United States $0.162B 4.41
ARAVIVE, INC (ARAV) United States $0.156B 0.00
Dyadic (DYAI) United States $0.155B 0.00
PHASEBIO PHARMA (PHAS) United States $0.151B 0.00
Clearside Biomedical (CLSD) United States $0.139B 0.00
Selecta Biosciences (SELB) United States $0.138B 0.00
Verastem (VSTM) United States $0.137B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Applied Genetic Technologies (AGTC) United States $0.132B 0.00
Menlo Therapeutics (MNLO) United States $0.132B 0.00
Abeona Therapeutics (ABEO) United States $0.126B 0.00
Vaccinex (VCNX) United States $0.124B 0.00
Happiness Biotech Group (HAPP) China $0.122B 0.00
Northwest Biotherapeutics (NWBO) United States $0.120B 0.00
Aduro Biotech (ADRO) United States $0.119B 0.00
VTv Therapeutics (VTVT) United States $0.118B 0.00
Enzo Biochem (ENZ) United States $0.117B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.116B 0.00
OvaScience (MLND) United States $0.115B 0.00
Arsanis (XFOR) United States $0.114B 0.00
Celyad SA (CYAD) Belgium $0.110B 0.00
Liquidia Technologies (LQDA) United States $0.103B 0.00
Antibe Therapeutics (ATBPF) Canada $0.103B 0.00
SESEN BIO, INC (SESN) United States $0.103B 0.00
Acorda Therapeutics (ACOR) United States $0.101B 0.00
Proteostasis Therapeutics (PTI) United States $0.090B 0.00
AIT Therapeutics (XAIR) United States $0.089B 0.00
Synlogic (SYBX) United States $0.087B 0.00
Adocia (ADOCY) France $0.086B 0.00
Trevena (TRVN) United States $0.086B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.085B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.082B 0.00
Catalyst Biosciences (CBIO) United States $0.081B 0.00
Orgenesis (ORGS) United States $0.078B 5.03
Prima BioMed (IMMP) Australia $0.078B 0.00
Checkpoint Therapeutics (CKPT) United States $0.073B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.067B 0.00
NewLink Genetics (NLNK) United States $0.064B 0.00
Soligenix (SNGX) United States $0.060B 0.00
Pluristem Therapeutics (PSTI) Israel $0.059B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.059B 0.00
Emmaus Life Sciences (EMMA) United States $0.058B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.056B 0.00
Vascular Biogenics (VBLT) Israel $0.055B 0.00
Curis (CRIS) United States $0.055B 0.00
Protalix BioTherapeutics (PLX) Israel $0.054B 0.00
Idera Pharmaceuticals (IDRA) United States $0.051B 0.00
Signal Genetics (MGEN) United States $0.050B 0.00
DiaMedica Therapeutics (DMAC) United States $0.050B 0.00
AmpliPhi Biosciences (ARMP) United States $0.048B 0.00
Organovo Holdings (ONVO) United States $0.046B 0.00
AquaBounty Technologies (AQB) United States $0.045B 0.00
CollPlant Holdings (CLGN) Israel $0.042B 0.00
Evogene (EVGN) Israel $0.041B 0.00
Celldex Therapeutics (CLDX) United States $0.038B 0.00
Entera Bio (ENTX) Israel $0.036B 0.00
Pulmatrix (PULM) United States $0.036B 0.00
Alimera Sciences (ALIM) United States $0.035B 0.00
Celsion (CLSN) United States $0.034B 0.00
BioCardia (BCDA) United States $0.034B 0.00
VistaGen Therapeutics (VTGN) United States $0.033B 0.00
Cleveland BioLabs (CBLI) United States $0.032B 0.00
Bionano Genomics (BNGO) United States $0.030B 0.00
Unum Therapeutics (UMRX) United States $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.029B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.027B 0.00
Oncobiologics (OTLK) United States $0.026B 0.00
Novogen (KZIA) Australia $0.026B 0.00
Stellar Biotechnologies (EDSA) Canada $0.026B 0.00
VIVUS (VVUS) United States $0.024B 0.00
AEterna Zentaris (AEZS) United States $0.023B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.022B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
Titan Pharmaceuticals (TTNP) United States $0.016B 0.00
Cesca Therapeutics (THMO) United States $0.015B 0.00
Advaxis (ADXS) United States $0.014B 0.00
TrovaGene (TROV) United States $0.014B 0.00
TRACON Pharmaceuticals (TCON) United States $0.013B 0.00
TOCAGEN INC (TOCA) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.012B 0.00
Prana Biotechnology (ATHE) Australia $0.012B 0.00
BioPharmX (BPMX) United States $0.011B 0.00
IBio (IBIO) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.004B 0.00